ADC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.

About ADCT

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602.

CEO

Ameet Mallik

CEOAmeet Mallik

Employees

265

Employees265

Headquarters

Epalinges, Vaud

HeadquartersEpalinges, Vaud

Founded

2011

Founded2011

Employees

265

Employees265

ADCT Key Statistics

Market cap

187.94M

Market cap187.94M

Price-Earnings ratio

-1.30

Price-Earnings ratio-1.30

Dividend yield

—

Dividend yield—

Average volume

519.32K

Average volume519.32K

High today

$1.90

High today$1.90

Low today

$1.70

Low today$1.70

Open price

$1.77

Open price$1.77

Volume

426.74K

Volume426.74K

52 Week high

$4.23

52 Week high$4.23

52 Week low

$1.05

52 Week low$1.05

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ADCT. This list is generated using Robinhood data, and it’s not a recommendation.